Urologix, Inc. (ULGX) Reports Q4 Loss of $0.17/Share
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Join SI Premium – FREE
Urologix, Inc. (: ULGX) reported Q4 EPS of ($0.17), versus ($0.16) reported last year. Revenue for the quarter came in at $3.29 million, versus $4.18 million reported last year.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
